Impact of intraperitoneal chemotherapy after gastrectomy with positive cytological findings in peritoneal washings

European Surgical Research

Volumn 47, Issue 4, 2011, Pages 254-259

  Imano, M ^a,b   Imamoto, H ^a   Itoh, T ^a   Satou, T ^a   Peng, Y F ^a   Yasuda, A ^a   Kato, H ^a   Nishiki, K ^a   Shiraishi, O ^a   Shinkai, M ^a   Tsubaki, M ^c   Yasuda, T ^a   Nishida, S ^c   Takeyama, Y ^a,b   Okuno, K ^a   Shiozaki, H ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KINDAI UNIVERSITY HOSPITAL   (Japan)

^c KINKI UNIVERSITY   (Japan)

Author keywords

Gastrectomy; Gastric cancer; Intraperitoneal chemotherapy

Indexed keywords

PACLITAXEL;

ABDOMINAL PAIN; ADULT; AGED; ANEMIA; ANOREXIA; ANTIBIOTIC THERAPY; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; CYTOLOGICAL FINDINGS IN PERITONEAL WASHING; CYTOPATHOLOGY; DIARRHEA; DRUG ADMINISTRATION ROUTE; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; GASTRECTOMY; HUMAN; HUMAN TISSUE; LEUKOPENIA; LYMPH NODE DISSECTION; LYMPHADENECTOMY; MALE; MUCOSA INFLAMMATION; NAUSEA AND VOMITING; NEUROPATHY; NEUTROPENIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RASH; SINGLE DRUG DOSE; STOMACH CANCER; SURGICAL INFECTION; THROMBOCYTOPENIA;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HUMANS; INFUSIONS, PARENTERAL; MALE; MIDDLE AGED; PERITONEAL CAVITY; PERITONEAL LAVAGE; PROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 80455128195     PISSN: 0014312X     EISSN: 14219921     Source Type: Journal    
DOI: 10.1159/000333803     Document Type: Article

References (23)

1. Hundahl SA, Menck HR, Mansour EG, Winchester DP: The National Cancer Data Base report on gastric carcinoma. Cancer 1997; 80: 2333-2341. (Pubitemid 28007405)
2. Siewert JR, Bottcher K, Roder JD, Busch R, Hermanek P, Meyer HJ: Prognostic relevance of systematic lymph node dissection in gastric carcinoma. German Gastric Carcinoma Study Group. Br J Surg 1993; 80: 1015-1018. (Pubitemid 23261584)
3. Allum WH, Powell DJ, McConkey CC, Fielding JW: Gastric cancer: a 25-year review. Br J Surg 1989; 76: 535-540. (Pubitemid 19155720)
4. Suzuki T, Ochiai T, Hayashi H, Nakajima K, Yasumoto A, Hishikawa E, Shimada H, Horiuchi F, Ohki S, Isono K: Importance of positive peritoneal lavage cytology findings in the stage grouping of gastric cancer. Surg Today 1999; 29: 111-115. (Pubitemid 29088856)
5. Kodera Y, Yamamura Y, Shimizu Y, Torii A, Hirai T, Yasui K, Morimoto T, Kato T: Peritoneal washing cytology: prognostic value of positive findings in patients with gastric carcinoma undergoing a potentially curative resection. J Surg Oncol 1999; 72: 60-64, discussion 64-65.
6. Bonenkamp JJ, Songun I, Hermans J, van de Velde CJ: Prognostic value of positive cytology findings from abdominal washings in patients with gastric cancer. Br J Surg 1996; 83: 672-674. (Pubitemid 26163552)
7. Bentrem D, Wilton A, Mazumdar M, Brennan M, Coit D: The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection. Ann Surg Oncol 2005; 12: 347-353.
8. Markman M, Rowinsky E, Hakes T, Reichman B, Jones W, Lewis JL Jr, Rubin S, Curtin J, Barakat R, Phillips M, et al: Phase I trial of intraperitoneal taxol: a Gynecologic Oncology Group study. J Clin Oncol 1992; 10: 1485-1491.
9. Hofstra LS, Bos AM, de Vries EG, van der Zee AG, Willemsen AT, Rosing H, Beijnen JH, Mulder NH, Aalders JG, Willemse PH: Kinetic modeling and efficacy of intraperitoneal paclitaxel combined with intravenous cyclophosphamide and carboplatin as firstline treatment in ovarian cancer. Gynecol Oncol 2002; 85: 517-523. (Pubitemid 34651895)
10. Francis P, Rowinsky E, Schneider J, Hakes T, Hoskins W, Markman M: Phase I feasibility and pharmacologic study of weekly intraperitoneal paclitaxel: a Gynecologic Oncology Group pilot study. J Clin Oncol 1995; 13: 2961-2967.
11. Mohamed F, Marchettini P, Stuart OA, Yoo D, Sugarbaker PH: A comparison of hetastarch and peritoneal dialysis solution for intraperitoneal chemotherapy delivery. Eur J Surg Oncol 2003; 29: 261-265. (Pubitemid 36395562)
12. Kyle AH, Huxham LA, Yeoman DM, Minchinton AI: Limited tissue penetration of taxanes: a mechanism for resistance in solid tumors. Clin Cancer Res 2007; 13: 2804-2810. (Pubitemid 46788050)
13. Yoshikawa T, Omura K, Kobayashi O, Nashimoto A, Takabayashi A, Yamada T, Yamaue H, Fujii M, Yamaguchi T, Nakajima T: A phase II study of preoperative chemotherapy with S-1 plus cisplatin followed by D2/D3 gastrectomy for clinically serosa-positive gastric cancer (JACCRO GC-01 study). Eur J Surg Oncol 2010; 36: 546-551.
14. Schuhmacher C, Gretschel S, Lordick F, Reichardt P, Hohenberger W, Eisenberger CF, Haag C, Mauer ME, Hasan B, Welch J, Ott K, Hoelscher A, Schneider PM, Bechstein W, Wilke H, Lutz MP, Nordlinger B, Cutsem EV, Siewert JR, Schlag PM: Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954. J Clin Oncol 2010; 28: 5210-5218.
15. Japanese Gastric Cancer Association: Japanese Classification of Gastric Carcinoma - 2nd English Edition. Gastric Cancer 1998; 1: 10-24.
16. Hironaka S, Zenda S, Boku N, Fukutomi A, Yoshino T, Onozawa Y: Weekly paclitaxel as second-line chemotherapy for advanced or recurrent gastric cancer. Gastric Cancer 2006; 9: 14-18.
17. Longnecker SM, Donehower RC, Cates AE, Chen TL, Brundrett RB, Grochow LB, Ettinger DS, Colvin M: High-performance liquid chromatographic assay for taxol in human plasma and urine and pharmacokinetics in a phase I trial. Cancer Treat Rep 1987; 71: 53-59. (Pubitemid 17003433)
18. de Bree E, Rosing H, Filis D, Romanos J, Melisssourgaki M, Daskalakis M, Pilatou M, Sanidas E, Taflampas P, Kalbakis K, Beijnen JH, Tsiftsis DD: Cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy with paclitaxel: a clinical and pharmacokinetic study. Ann Surg Oncol 2008; 15: 1183-1192.
19. Wiernik PH, Schwartz EL, Strauman JJ, Dutcher JP, Lipton RB, Paietta E: Phase I clinical and pharmacokinetic study of taxol. Cancer Res 1987; 47: 2486-2493. (Pubitemid 17099218)
20. Fukagawa T, Katai H, Saka M, Morita S, Sasajima Y, Taniguchi H, Sano T, Sasako M: Significance of lavage cytology in advanced gastric cancer patients. World J Surg 2010; 34: 563-568.
21. Roviello F, Marrelli D, de Manzoni G, Morgagni P, Di Leo A, Saragoni L, De Stefano A: Prospective study of peritoneal recurrence after curative surgery for gastric cancer. Br J Surg 2003; 90: 1113-1119. (Pubitemid 37152170)
22. Otsuji E, Kuriu Y, Ichikawa D, Okamoto K, Hagiwara A, Yamagishi H: Characteristics of gastric carcinoma invading the muscularis propria. J Surg Oncol 2005; 92: 104-108. (Pubitemid 41572151)
23. Kodera Y, Imano M, Yoshikawa T, Takahashi N, Tsuburaya A, Miyashita Y, Morita S, Nakao A, Sakamoto J, Sasako M: A randomized phase II trial to test the efficacy of intra-peritoneal paclitaxel for gastric cancer with high risk for the peritoneal metastasis (INPACT trial). Jpn J Clin Oncol 2011; 41: 283-286